Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care

Journal of General Internal Medicine

Volumn 24, Issue 9, 2009, Pages 1065-1072

  Silverberg, Michael J ^a   Leyden, Wendy ^a   Quesenberry Jr , Charles P ^a   Horberg, Michael A ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

AIDS; Ethnicity; Race; Survival

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; HEALTH CARE ACCESS; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RACE DIFFERENCE; SOCIAL STATUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 68949205558     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-009-1049-y     Document Type: Article

References (38)

1. CDC 2007 Racial/ethnic disparities in diagnoses of HIV/AIDS-33 states, 2001-2005 MMWR Morb Mortal Wkly Rep 56 189 193
2. CDC. HIV/AIDS Surveillance Report, 2005. 2007;17:1-54.
3. Heron MP, Smith BL. Deaths: leading causes for 2003. Hyattsville, MD: National vital statistics reports; 2007;15:1-92.
4. K Anastos MF Schneider SJ Gange et al 2005 The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women J Acquir Immune Defic Syndr 39 537 544
5. TP Giordano RO Morgan JR Kramer et al 2006 Is there a race-based disparity in the survival of veterans with HIV? J Gen Intern Med 21 613 617
6. S Jensen-Fangel L Pedersen C Pedersen et al 2002 The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients Clin Infect Dis 35 1541 1548
7. KE Poundstone RE Chaisson RD Moore 2001 Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy AIDS 15 1115 1123
8. MJ Silverberg SA Wegner MJ Milazzo et al 2006 Effectiveness of highly-active antiretroviral therapy by race/ethnicity AIDS 20 1531 1538
9. PR Smith L Sarner M Murphy et al 2003 Ethnicity and discordance in plasma HIV-1 RNA viral load and CD4+ lymphocyte count in a cohort of HIV-1-infected individuals J Clin Virol 26 101 107
10. EM Tedaldi J Absalon AJ Thomas JC Shlay M van den Berg-Wolf 2008 Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study) J Acquir Immune Defic Syndr 47 441 448
11. KA McGinnis MJ Fine RK Sharma et al 2003 Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data Am J Public Health 93 1728 1733
12. NA Merriman SB Porter CM Brensinger KR Reddy KM Chang 2006 Racial difference in mortality among U.S. veterans with HCV/HIV coinfection Am J Gastroenterol 101 760 767
13. P Messeri G Lee DM Abramson A Aidala MA Chiasson DJ Jessop 2003 Antiretroviral therapy and declining AIDS mortality in New York City Med Care 41 512 521
14. Gordon NP. How does the adult kaiser permanente membership in Northern California compare with the larger community? Oakland: KP Division of Research; 2009. Available at: http://www-dor.kaiser.org/dor/mhsnet/public/kpnc-community. htm. Accessed June 4, 2009.
15. US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-Infected adults and adolescents. Available at: http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Accessed June 4, 2009.
16. MA Horberg LB Hurley MJ Silverberg CJ Kinsman CP Quesenberry 2007 Effect of clinical pharmacists on utilization of and clinical response to antiretroviral therapy J Acquir Immune Defic Syndr 44 531 539
17. MJ Silverberg W Leyden MA Horberg GN DeLorenze D Klein CP Quesenberry Jr 2007 Older age and the response to and tolerability of antiretroviral therapy Arch Intern Med 167 684 691
18. JF Steiner AV Prochazka 1997 The assessment of refill compliance using pharmacy records: methods, validity, and applications J Clin Epidemiol 50 105 116
19. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. 1992;41:1-19.
20. RB Bendel AA Afifi 1977 Comparison of stopping rules in forward "stepwise" regression J Am Stat Assoc 72 46 53
21. Hosmer DW, Lemeshow S. Applied logistic regression, second edition. Hoboken, NJ: John Wiley & Sons, Inc.; 2000.
22. Cox DR, Oates D. Analysis of survival data. London and New York: Chapman and Hall; 1984.
23. Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. New York, NY: Oxford University Press; 1995.
24. Epidemiology of HIV/AIDS-United States, 1981-2005. MMWR Morb Mortal Wkly Rep. Jun 2 2006;55:589-92.
25. DE Hayes-Bautista L Baezconde-Garbanati WO Schink M Hayes-Bautista 1994 Latino health in California, 1985-1990: implications for family practice Fam Med 26 556 562
26. KS Markides J Coreil 1986 The health of Hispanics in the southwestern United States: an epidemiologic paradox Public Health Rep 101 253 265
27. N Krieger 1992 Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology Am J Public Health 82 703 710
28. CA Kleeberger JP Phair SA Strathdee R Detels L Kingsley LP Jacobson 2001 Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study J Acquir Immune Defic Syndr 26 82 92
29. CA Kleeberger J Buechner F Palella et al 2004 Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study AIDS 18 683 688
30. X Li JB Margolick CS Conover et al 2005 Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study J Acquir Immune Defic Syndr 38 320 328
31. CE Golin H Liu RD Hays et al 2002 A prospective study of predictors of adherence to combination antiretroviral medication J Gen Intern Med 17 756 765
32. AL Gifford JE Bormann MJ Shively BC Wright DD Richman SA Bozzette 2000 Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens J Acquir Immune Defic Syndr 23 386 395
33. CJ Smith CA Sabin MS Youle et al 2004 Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy J Infect Dis 190 1860 1868
34. JD Hartzell K Spooner R Howard S Wegner G Wortmann 2007 Race and mental health diagnosis are risk factors for highly active antiretroviral therapy failure in a military cohort despite equal access to care J Acquir Immune Defic Syndr 44 411 416
35. BR Schackman HJ Ribaudo A Krambrink V Hughes DR Kuritzkes RM Gulick 2007 Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095 J Acquir Immune Defic Syndr 46 547 554
36. PN Kumar A Rodriguez-French MA Thompson et al 2006 A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/ nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity HIV Med 7 85 98
37. TP Giordano JA Wright MQ Hasan AC White Jr. EA Graviss F Visnegarwala 2003 Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy? Clin Infect Dis 37 433 437
38. GM Lucas RE Chaisson RD Moore 1999 Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions Ann Intern Med 131 81 87